We are live on
!
Find out more
RIM
RS Investment Management Portfolio holdings
AUM
$9.73B
1-Year Est. Return
3.24%
This Fund
S&P 500
This Quarter
Est. Return
+5.36%
1 Year Est. Return
+3.24%
3 Year Est. Return
+50.37%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$9.73B
AUM Growth
-$385M
(-3.8%)
Cap. Flow
-$739M
Cap. Flow
% of AUM
-7.6%
Top 10 Holdings %
Top 10 Hldgs %
14.92%
Holding
438
New
62
Increased
134
Reduced
162
Closed
56
Top Buys
| 1 |
Kirby Corp
KEX
|
+$55M |
| 2 |
Integra LifeSciences
IART
|
+$51.1M |
| 3 |
LSXMK
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
|
+$45.4M |
| 4 |
WBMD
WebMD Health Corp.
WBMD
|
+$43.4M |
| 5 |
Ingevity
NGVT
|
+$39.8M |
Top Sells
| 1 |
Myriad Genetics
MYGN
|
+$81.5M |
| 2 |
Steris
STE
|
+$57.7M |
| 3 |
Red Robin
RRGB
|
+$56.8M |
| 4 |
Dollar General
DG
|
+$52.6M |
| 5 |
Zebra Technologies
ZBRA
|
+$48.1M |
Sector Composition
| 1 | Technology | 17.3% |
| 2 | Healthcare | 14.02% |
| 3 | Financials | 14.01% |
| 4 | Consumer Discretionary | 13.08% |
| 5 | Industrials | 12.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Wabtec
WAB
$44.8B
| $28.6M | 0.29% |
406,796
+120,500
| +42% | +$9.36M |
|
|
BDN
127
Brandywine Realty Trust
BDN
$554M
| $28.6M | 0.29% |
1,700,007
-94,660
| -5% | -$1.44M |
|
128
SEI Investments
SEIC
$12.1B
| $28.4M | 0.29% |
590,598
+42,688
| +8% | +$2.05M |
|
|
VRE
129
DELISTED
Veris Residential
VRE
| $28.3M | 0.29% |
1,048,325
-165,316
| -14% | -$4.23M |
|
|
PVTB
130
DELISTED
PrivateBancorp Inc
PVTB
| $28.2M | 0.29% |
641,502
-528,248
| -45% | -$21.5M |
|
131
Synopsys
SNPS
$79.9B
| $28.1M | 0.29% |
519,330
+73,375
| +16% | +$3.68M |
|
132
Dave & Buster's
PLAY
$367M
| $28.1M | 0.29% |
599,832
+19,220
| +3% | +$797K |
|
133
Pfizer
PFE
$143B
| $27.9M | 0.29% |
835,827
-897,966
| -52% | -$28.7M |
|
|
WNS
134
DELISTED
WNS Holdings
WNS
| $27.8M | 0.29% |
+1,029,418
| New | +$31.4M |
|
135
NorthWestern Energy
NWE
$4.51B
| $26.9M | 0.28% |
427,000
-13,270
| -3% | -$786K |
|
136
Bristol-Myers Squibb
BMY
$124B
| $26.9M | 0.28% |
366,010
-159,990
| -30% | -$11.3M |
|
137
WEX
WEX
$5.69B
| $26.6M | 0.27% |
+300,500
| New | +$26.8M |
|
138
Edison International
EIX
$30B
| $26.2M | 0.27% |
337,250
+2,730
| +0.8% | +$196K |
|
|
CAVM
139
DELISTED
Cavium, Inc.
CAVM
| $25.4M | 0.26% |
658,444
-556,286
| -46% | -$27.5M |
|
|
ACRE
140
Ares Commercial Real Estate
ACRE
$261M
| $25.3M | 0.26% |
2,059,199
-200,799
| -9% | -$2.37M |
|
141
Casey's General Stores
CASY
$30.6B
| $25.3M | 0.26% |
192,160
-170,363
| -47% | -$19.8M |
|
|
BLUE
142
DELISTED
bluebird bio
BLUE
| $24.9M | 0.26% |
44,397
+3,654
| +9% | +$2.07M |
|
143
Wingstop
WING
$3.84B
| $24.9M | 0.26% |
912,837
-369,366
| -29% | -$9.61M |
|
144
Universal Health Services
UHS
$9.29B
| $24.8M | 0.25% |
184,694
-42,919
| -19% | -$5.66M |
|
145
LyondellBasell Industries
LYB
$18.7B
| $24.7M | 0.25% |
332,066
+7,790
| +2% | +$643K |
|
|
146
Steris
STE
$21.6B
| $24.7M | 0.25% |
358,849
-824,018
| -70% | -$57.7M |
|
|
TXNM
147
TXNM Energy Inc
TXNM
$6.37B
| $24.7M | 0.25% |
696,060
-7,060
| -1% | -$232K |
|
148
PNC Financial Services
PNC
$102B
| $24.7M | 0.25% |
303,065
+3,806
| +1% | +$327K |
|
149
DexCom
DXCM
$30.1B
| $24.6M | 0.25% |
1,238,604
-1,697,740
| -58% | -$28.9M |
|
150
Performance Food Group
PFGC
$17.8B
| $24.5M | 0.25% |
910,382
+111,853
| +14% | +$2.83M |
|
Similar funds
SG
KGI
VAM
FBNAT
CPS
LH
CPM
VFS
RS Investment Management's Q2 2016 Portfolio in Review
As of Q2 2016, RS Investment Management held 438 positions worth $9.73B, down 3.8% from $10.1B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
RS Investment Management withdrew a net $739M in Q2 2016, closing 56 positions and reducing 162 holdings. Its most notable exit was Myriad Genetics, an estimated $81.5M position sold in full.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.
Against the trend, RS Investment Management opened a new position in Kirby Corp worth $52.4M.
- RS Investment Management's largest Q2 2016 buy was Kirby Corp: 839,753 shares worth $52.4M.
- RS Investment Management added most to Allergan plc in Q2 2016, an estimated $36.7M increase.
- RS Investment Management's biggest Q2 2016 reduction was Steris, cutting an estimated $57.7M.
- RS Investment Management fully exited Myriad Genetics in Q2 2016, selling an estimated $81.5M.
- RS Investment Management's ten largest holdings make up 15% of its $9.73B portfolio in Q2 2016.
- RS Investment Management opened 62 new positions and closed 56 in Q2 2016.
- RS Investment Management's portfolio value fell 3.8% quarter-over-quarter to $9.73B.
Based on RS Investment Management's 13F filing for Q2 2016, filed 26 Jul 2016.